Target intelligence / Profile preview

Heme metabolism proteins of Plasmodium falciparum

Molecular classification
Enzyme, Other (heme-binding proteins), Metabolic pathway component
01

Overview

Proteins involved in heme metabolism in Plasmodium falciparum are central therapeutic targets for antimalarial drugs. During its intraerythrocytic stage, P. falciparum digests host hemoglobin within its acidic food vacuole, releasing large amounts of potentially toxic free heme[1][8]. To avoid toxicity, the parasite converts this free heme into inert crystalline hemozoin via specialized proteins such as the heme detoxification protein (HDP)[1], among others involved in this process[4][5]. Some antimalarial drugs—including chloroquine—act by inhibiting this conversion process; failure to sequester toxic heme results in oxidative damage and death of the parasite[4]. Artemisinin derivatives act through a distinct but related mechanism—they are activated by iron(II) or labile ferrous centers found predominantly within these same compartments rich in hemoglobin digestion products. Upon activation via cleavage of their endoperoxide bridge by Fe(II)/heme species present inside infected erythrocytes' food vacuoles, they generate highly reactive carbon-centered radicals that alkylate numerous essential parasite proteins across various cellular compartments[6]. Thus their action is pleiotropic rather than directed at a single molecular entity. Additional potential targets may be engaged depending on which partner drug is combined with artemisinins—for example inhibitors targeting mitochondrial electron transport chain components like cytochrome bc1 when using atovaquone as a partner drug[5]. Because these entries refer collectively to several related but distinct molecules/pathways—and because some mechanisms involve non-protein chemical reactivity—the term "multiple targets" here does not correspond to one canonical gene/protein product but rather encompasses an array of functionally linked molecules critical for malaria pathogenesis and therapy response. If you need structured information about individual components such as "Heme detoxification protein," "Plasmodium falciparum ferrochelatase," or specific redox-sensitive enzymes targeted by artemisinins specifically identified through chemoproteomics studies,[6] please specify so each can be mapped precisely according to your conventions.

Other names
Heme detoxification protein (HDP)Hemozoin formation pathwayHeme oxygenase-like protein (PfHO)Food vacuole heme-binding proteinsBlood-stage heme metabolism enzymes
02

Mechanism of action

1. Artemisinins: Activated by iron(II) or heme within the parasite food vacuole to generate cytotoxic free radicals that alkylate multiple parasite proteins[6]. These include enzymes involved in redox homeostasis, hemoglobin digestion, and other essential processes. 2. Chloroquine/Quinine: Inhibit the polymerization of toxic free heme into inert hemozoin crystals within the food vacuole[4][8]. Accumulation of toxic free heme leads to parasite death. 3. Partner drugs: Mechanisms vary—may inhibit different metabolic pathways or transporters depending on the compound used.

03

Biological functions

Heme detoxificationHemoglobin catabolismOxidative stress responseIron acquisition and storage
04

Disease associations

Infection (malaria)
05

Safety considerations

Emergence of resistance due to mutations affecting drug activation or target engagement.Off-target toxicity if host cell pathways are inadvertently affected by reactive intermediates generated by antimalarials.
06

Interacting drugs

Artemisinin and derivatives (e.g., artesunate, artemether)

2 more in the full profile.

07

Biomarkers

Parasite clearance rate after treatment with artemisinin-based combination therapies can serve as an indirect biomarker for efficacy.Levels of circulating parasitic DNA/RNA or detection of mutant alleles associated with resistance may be monitored.

Beyond the preview

Go deeper on Heme metabolism proteins of Plasmodium falciparum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heme metabolism proteins of Plasmodium falciparum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call